New insights into long noncoding RNAs and pseudogenes in prognosis of renal cell carcinoma

The Emergence of Precision Urologic Oncology: A Collaborative Review on Biomarker-driven Therapeutics

(2017) Christopher E. Barbieri et al.   EUROPEAN UROLOGY

Long non-coding RNA LINC01133 inhibits epithelial–mesenchymal transition and metastasis in colorectal cancer by interacting with SRSF6

(2016) Jianlu Kong et al.   CANCER LETTERS

A serum-circulating long noncoding RNA signature can discriminate between patients with clear cell renal cell carcinoma and healthy controls

(2016) Y Wu et al.   Oncogenesis

Are Human Translated Pseudogenes Functional?

(2015) Jinrui Xu et al.   MOLECULAR BIOLOGY AND EVOLUTION

Pseudogene integrator complex subunit 6 pseudogene 1 (INTS6P1) as a novel plasma-based biomarker for hepatocellular carcinoma screening

(2015) Ka Yin Lui et al.   TUMOR BIOLOGY

Prognostic value of meta-signature miRNAs in renal cell carcinoma: an integrated miRNA expression profiling analysis

(2015) Kun Tang et al.   Scientific Reports

Pseudogene PTENP1 Functions as a Competing Endogenous RNA to Suppress Clear-Cell Renal Cell Carcinoma Progression

(2014) G. Yu et al.   MOLECULAR CANCER THERAPEUTICS

The pseudogene TUSC2P promotes TUSC2 function by binding multiple microRNAs

(2014) Zina Jeyapalan Rutnam et al.   Nature Communications

Long Noncoding RNAs: Past, Present, and Future

(2013) J. T. Y. Kung et al.   GENETICS

Molecular Marker for Predicting Treatment Response in Advanced Renal Cell Carcinoma: Does the Promise Fulfill Clinical Need?

(2013) Michael Garcia-Roig et al.   Current Urology Reports

Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trials

(2012) Hai T Tran et al.   LANCET ONCOLOGY

A cytokine and angiogenic factor (CAF) analysis in plasma for selection of sorafenib therapy in patients with metastatic renal cell carcinoma

(2011) A. J. Zurita et al.   ANNALS OF ONCOLOGY

OCT4 pseudogenes present in human leukemia cells

(2011) Xiaoping Guo et al.   CLINICAL AND EXPERIMENTAL MEDICINE

Expression of OCT4 pseudogenes in human tumours: lessons from glioma and breast carcinoma

(2010) Shidou Zhao et al.   JOURNAL OF PATHOLOGY

Epidemiology and risk factors for kidney cancer

(2010) Wong-Ho Chow et al.   Nature Reviews Urology

Sorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial

(2009) Bernard Escudier et al.   JOURNAL OF CLINICAL ONCOLOGY

Therapy for metastatic RCC—questions remain

(2009) Rodney H. Breau et al.   Nature Reviews Urology

HIF-α Effects on c-Myc Distinguish Two Subtypes of Sporadic VHL-Deficient Clear Cell Renal Carcinoma

(2008) John D. Gordan et al.   CANCER CELL

A three-gene expression signature model to predict clinical outcome of clear cell renal carcinoma

(2008) Masahiro Yao et al.   INTERNATIONAL JOURNAL OF CANCER

Tuning in to the signals: noncoding sequence conservation in vertebrate genomes

(2008) Greg Elgar et al.   TRENDS IN GENETICS